T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells

被引：0
|
作者：
K Mihara
J Bhattacharyya
A Kitanaka
K Yanagihara
T Kubo
Y Takei
H Asaoku
Y Takihara
A Kimura
机构：
[1] Research Institute for Radiation Biology and Medicine,Department of Hematology and Oncology
[2] Hiroshima University,Department of Laboratory Medicine
[3] Faculty of Medicine,Department of Life Science
[4] Kagawa University,Department of Biochemistry
[5] Yasuda Women’s University Faculty of Pharmacy,Department of Clinical Laboratory
[6] Nagoya University Graduate School of Medicine,Department of Stem Cell Biology
[7] Hiroshima Red Cross Hospital & Atomic-Bomb Survivors Hospital,undefined
[8] Research Institute for Radiation Biology and Medicine,undefined
[9] Hiroshima University,undefined
来源：
Leukemia | 2012年 / 26卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：365 / 367
页数：2
相关论文
共 50 条
  • [1] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eliminating myeloma cells
    Mihara, K.
    Bhattacharyya, J.
    Kitanaka, A.
    Yanagihara, K.
    Kubo, T.
    Takei, Y.
    Asaoku, H.
    Takihara, Y.
    Kimura, A.
    LEUKEMIA, 2012, 26 (02) : 365 - 367
  • [2] T-Cell Immunotherapy with a Chimeric Receptor Against CD38 Is Effective in Eliminating Myeloma Cells
    Mihara, Keichiro
    Bhattacharyya, Joyeeta
    Kitanaka, Akira
    Ihara, Akihiro
    Sakai, Akira
    Kuroda, Yoshiaki
    Asaoku, Hideki
    Takihara, Yoshihiro
    Kimura, Akiro
    BLOOD, 2011, 118 (21) : 405 - 405
  • [3] Activated T cell-mediated immunotherapy with a chimeric receptor against CD38 in B-cell malignancies
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Ochiya, Takahiro
    Imai, Chihaya
    Kitanaka, Akira
    Takihara, Yoshihiro
    Kimuna, Akiro
    BLOOD, 2007, 110 (11) : 696A - 696A
  • [4] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1
    Bhattacharyya, J.
    Mihara, K.
    Kitanaka, A.
    Yanagihara, K.
    Kubo, T.
    Takei, Y.
    Kimura, A.
    Takihara, Y.
    BLOOD CANCER JOURNAL, 2012, 2 : e75 - e75
  • [5] T-cell immunotherapy with a chimeric receptor against CD38 is effective in eradicating chemotherapy-resistant B-cell lymphoma cells overexpressing survivin induced by BMI-1
    J Bhattacharyya
    K Mihara
    A Kitanaka
    K Yanagihara
    T Kubo
    Y Takei
    A Kimura
    Y Takihara
    Blood Cancer Journal, 2012, 2 : e75 - e75
  • [6] CD38 Chimeric Antigen Receptor Engineered T Cells As Therapeutic Tools for Multiple Myeloma
    Drent, Esther
    Groen, Richard
    Noort, Willy A.
    van Bueren, Jeroen Lammerts
    Parren, Paul W. H. I.
    Kuball, Jurgen H.
    Sebestyen, Zsolt
    van de Donk, Niels W. C. J.
    Martens, Anton C.
    Lokhorst, Henk M.
    Mutis, Tuna
    BLOOD, 2014, 124 (21)
  • [7] ALLOGENEIC TCRA/CD38 DOUBLE KNOCKOUT T-CELLS BEARING AN ANTI-CD38 CHIMERIC ANTIGEN RECEPTOR: AN IMPROVED IMMUNOTHERAPY FOR THE TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND MULTIPLE MYELOMA
    Dusseaux, M.
    Le Clerre, D.
    Gouble, A.
    Smith, J.
    HAEMATOLOGICA, 2016, 101 : 122 - 123
  • [8] Activated T-cell-mediated Immunotherapy With a Chimeric Receptor Against CD38 in B-cell Non-Hodgkin Lymphoma
    Mihara, Keichiro
    Yanagihara, Kazuyoshi
    Takigahira, Misato
    Imai, Chihaya
    Kitanaka, Akira
    Takihara, Yoshihiro
    Kimura, Akiro
    JOURNAL OF IMMUNOTHERAPY, 2009, 32 (07) : 737 - 743
  • [9] Characterization of the Therapeutic Effects of Novel Chimeric Antigen Receptor T Cells Targeting CD38 on Multiple Myeloma
    Li, Xiaorui
    Feng, Yaru
    Shang, Fengqin
    Yu, Zhuoying
    Wang, Tieshan
    Zhang, Jing
    Song, Zhiru
    Wang, Ping
    Shi, Bingjie
    Wang, Jianxun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [10] Pre-clinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
    Drent, Esther
    Groen, Richard W. J.
    Noort, Willy A.
    Themeli, Maria
    van Bueren, Jeroen J. Lammerts
    Parren, Paul W. H. I.
    Kuball, Jurgen
    Sebestyen, Zsolt
    Yuan, Huipin
    de Bruijn, Joost
    van de Donk, Niels W. C. J.
    Martens, Anton C. M.
    Lokhorst, Henk M.
    Mutis, Tuna
    HAEMATOLOGICA, 2016, 101 (05) : 616 - 625
12345